Glaukos
GKOS · NYSE
Bulios Fair Price
$96.86
40.9% downside
Current Price
$163.82
According to Bulios Fair Price, GKOS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Glaukos Corporation is an American biotechnology company focused on the development and manufacture of innovative ophthalmic products. Founded in 1998, its headquarters are located in San Clemente, California. Glaukos specializes in the treatment of glaucoma and other eye diseases using new technologies, including implants and micro-surgical solutions. The company focuses on improving patients' quality of life through groundbreaking products and services that bring innovation to the field of ophthalmology.
Sector
Healthcare
Industry
Medical - Devices
CEO
Thomas William Burns
Employees
1,094
Headquarters
Aliso Viejo
Upcoming events
Earnings
Upcoming earnings report